Ecotoxicity & Biological Degradation
Regulatory
Biocorrosion & Material Testing
Medical Device Hygiene & Biocomp
Efficacy Antifouling
Clinical Study Services
Efficacy Biocides
Efficacy Household Hygiene
Biofilm Services

News from our company

Show all news
July 6, 2026
New ERP System to Go Live on 15 July 2026
In the course of the ongoing improvement of our internal processes, we will be implementing a new ERP system at Dr. Brill + Partner GmbH Institute for Hygiene and Microbiology in mid-July. By introducing this new system, we aim to further optimize our processes in the long term. For you as a customer, this means, in particular: Faster processing times and improved service quality in the long term Even higher data quality and improved traceability More efficient internal processes through greater system integration This new ERP system is already being used successfully in other divisions of DR. Brill INSTITUTES. We can therefore assure you that, once the transition is complete, we will be able to process your orders even more reliably and quickly. During the transition phase, there may be minor changes to the appearance of our documents - but all content, processes, and quality standards will, of course, remain unchanged. If you have any questions or comments regarding the transition, we are always happy to assist you - see CONTACT. We look forward to further strengthening our partnership with our valued customers through this system transition.
July 6, 2026
Hydrotox continues to grow!
As of 1 July 2026, Hydrotox Labor für Ökotoxikologie und Gewässerschutz GmbH was able to lease additional space totaling 170 m² in its existing building in Freiburg. As a result, the laboratory space will be expanded over the next few weeks by approximately 30 %, while the office space was nearly doubled immediately. With this expansion, Hydrotox - after more than 30 years in the same premises - now has the opportunity to position itself for the future, serve its customers in an even more service-oriented manner, and increase its testing capacity. If you are interested in taking a look at the new space during an in-person meeting in Freiburg, please feel free to contact us - we would love to show you around! CONTACT
June 18, 2026
Action Required: IUCLID Obligation for Renewal Applications of Biocidal Active Substances from 1 July 2026
From 1 July 2026, a new requirement issued by ECHA comes into effect: for all renewal applications for the approval of biocidal active substances, the dossier data must be submitted mandatorily in IUCLID format. What is changing? ECHA has stipulated that, for renewal applications submitted from 1 July 2026 onwards, the following data must be available in IUCLID format: All documentation from the original application for approval of the biocidal active substance All relevant approval data in accordance with the Biocidal Products Regulation (BPR) The data must be created or updated using the current version of IUCLID Applications that do not comply with the new format requirements risk delays or rejection of the renewal procedure. What does this mean for you? If your company is planning a renewal of the active substance approval, or has already submitted an application, you must ensure that your existing dossier: Has been updated to the latest version of IUCLID Contains all relevant data completely and correctly in IUCLID format Meets the formal requirements of the BPR We are here to support you – efficiently and competently Our Regulatory Affairs team has many years of experience in the preparation and updating of IUCLID dossiers for biocidal active substances. We are happy to assist you with migrating your dossier to the current version of IUCLID. Get in touch today Contact us today for a non-binding consultation – here: Contact Dr. Brill Regulatory Services – Your Trusted Partner for Biocidal Products Regulatory Compliance

Efficacy tests Disinfectants according to DIN EN 14885 | Preservation load tests according to Pharm. Eur. 5.1. 3 USP, ISO 11930 | Efficacy tests antifouling products according to ASTM D3623-78a and ASTM D6990-20 | In vitro toxicity tests according to ISO 10993-5, ISO 10993-23 | Validation reprocessing medical devices according to ISO 17664-1 and -2 | Efficacy tests antimicrobial and antiviral surfaces and treated articles according to ISO 22196, ISO 21702, ISO 20743 and ISO 18846 | Efficacy tests biofilm removal according to ASTM E2532 (CDC Reactor), ASTM 2799-12 (MBEC), ISO 85583-5 (flexible endoscopes) and according to Stürmer et al. (wound) | Tests on the resistance of car air conditioning systems to biofilms | Material tests on biogenic sulfuric acid corrosion | Investigations on microbially influenced metal corrosion | Implementation of research projects | Efficacy tests of household hygiene products according to EN 17658 | Preparation of registration documents for biocidal products